Systematic pan-cancer analysis reveals the prognostic and immunological roles of ectonucleoside triphosphate diphosphohydrolase 6

Figure 2 Ectonucleoside triphosphate diphosphohydrolase 6 expressions in gastrointestinal tumors. A-E: Immunohistochemistry staining results of ectonucleoside triphosphate diphosphohydrolase 6 (ENTPD6) expression in gastrointestinal tumors and adjacent normal tissues, including esophageal carcinoma, colon adenocarcinoma, stomach adenocarcinoma, pancreatic adenocarcinoma, rectal adenocarcinoma, scale bar: 200 μm; F: Differential expression plot of ENTPD6; G: The receiver operating characteristic curve and area under the curve value of ENTPD6 in six tumors. ^aP < 0.05; ^cP < 0.001. ESCA: Esophageal carcinoma; COAD: Colon adenocarcinoma; STAD: Stomach adenocarcinoma; PAAD: Pancreatic adenocarcinoma; READ: Rectal adenocarcinoma; ENTPD6: Ectonucleoside triphosphate diphosphohydrolase 6; AUC: Area under the curve.